Lamotrigine
Product Images NDC 13668-342

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 13668-342). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Torrent Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Clinicalstudy1 Partialonsetseizure

A responder rate chart displaying the improvement or worsening percentages of patients treated with Lamotrigine Extended-Release Tablets versus placebo. The graph plots responder rate on the vertical axis against the percent of patients on the horizontal axis for two groups: Lamotrigine Extended-Release Tablets (N=70) and placebo (N=73).*

FDA Label Image

Image Clinicalstudy2 Partialonsetseizure

A cumulative responder rate plot comparing Lamotrigine Extended-Release Tablets to placebo in patients. The x-axis shows percent of patients from 0 to 100, and the y-axis shows responder rate from -100% (worsening) to 100% (improvement). Two curves represent the outcomes for placebo and Lamotrigine, with Lamotrigine showing a higher responder rate overall.*

FDA Label Image

Label 100mg

Label for Lamotrigine Extended-Release Tablets, USP 100 mg, manufactured by Torrent Pharmaceuticals Limited. The label states the package contains 30 tablets, with storage instructions and a caution to verify the product dispensed. It includes a note to dispense the accompanying medication guide and features the Rx only designation. The label highlights "Once A Day" dosing and shows images of two round tablets marked 100 and 34.*

FDA Label Image

Label 200mg

Lamotrigine Extended-Release Tablets, USP 200 mg, label for a 30-tablet bottle by Torrent Pharmaceuticals Limited. The label includes dosage instructions, storage conditions, and a barcode. It displays the NDC 13668-342-30 and a statement to dispense the accompanying medication guide.*

FDA Label Image

Label 25mg

Lamotrigine Extended-Release Tablets, USP 25 mg label from Torrent Pharmaceuticals Limited. The label indicates a bottle of 30 tablets with strength of 25 mg each, includes storage and dispensing instructions, an NDC number, and a caution to verify the product dispensed. The label also features the Torrent Pharmaceuticals logo and specifies "Rx only." Tablets are shown as round and film-coated.*

FDA Label Image

Label 50mg

Label of Lamotrigine Extended-Release Tablets, USP 50 mg by Torrent Pharmaceuticals Limited. The label shows 30 tablets per container with NDC 13668-340-30. It advises verifying the product dispensed and proper storage conditions, includes a caution to dispense with a child-resistant closure, and states that the usual dosage is found in the prescribing information. The label features the labeler name and location and includes a barcode.*

FDA Label Image

Logo mg

FDA Label Image

Logo Pi

FDA Label Image

Structure

Chemical structure of lamotrigine showing a substituted aromatic ring with two chlorine atoms and two sulfonamide groups attached.*

FDA Label Image

Tabletsappearence

A data table depicting Lamotrigine tablets with strengths 25 mg, 50 mg, 100 mg, and 200 mg. Each row shows tablet color from light yellow to yellow, light green to green, light orange to orange, and light blue to blue respectively, along with illustrations of the tablet's upper and lower faces displaying specific imprint codes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.